Chloroform

Chloroform

SCHEMBL1654667

ClC(Cl)Cl.O=C(/C=C\c1ccccc1)/C=C/c1ccccc1.O=C(/C=C\c1ccccc1)/C=C/c1ccccc1.O=C(/C=C\c1ccccc1)/C=C/c1ccccc1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.83
▸ CYP2C9 P11712 3/20 0.83
▸ MAPT P10636 3/20 0.83
▸ PLIN1 O60240 2/20 0.83
▸ LMNA P02545 2/20 0.83
▸ RECQL P46063 2/20 0.83
▸ PLIN5 Q00G26 2/20 0.83
▸ ABHD5 Q8WTS1 2/20 0.83
▸ CYP2D6 P10635 2/20 0.83
▸ F3 P13726 2/20 0.83
▸ ALDH1A1 P00352 2/20 0.83
▸ SMN1; SMN2 Q16637 1/20 0.83
▸ HDAC3 O15379 2/20 0.61
▸ HDAC4 P56524 2/20 0.61
▸ HDAC1 Q13547 2/20 0.61
▸ HDAC2 Q92769 2/20 0.61
▸ HDAC8 Q9BY41 2/20 0.61
▸ HDAC6 Q9UBN7 2/20 0.61
▸ TNKS O95271 1/20 0.61
▸ HCAR2 Q8TDS4 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chloroform SCHEMBL5751924 1.00 CYP1A2 (0.83) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL3074804 1.00 CYP1A2 (0.83) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL1043119 1.00 CYP1A2 (0.83) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL84057 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL29371090 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL28370740 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL18788602 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL2128849 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL2832028 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA
Chloroform SCHEMBL7629150 0.98 CYP1A2 (0.79) CYP1A2CYP2C9MAPTPLIN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1864714-B1 Process for producing arylamine TOSOH CORP (JP) 2016-11-23 — — EP disclosed
US-20140299864-A1 POLYMERS CONTAINING THERMALLY DISSOCIABLE AND SOLUBLE GROUPS AND THE USE OF SUCH POLYMERS AS ORGANIC ELECTROLUMINESCENT MATERIALS MITSUBISHI CHEMICAL CORPORATION (JP) 2014-10-09 — — US disclosed
US-8795849-B2 Polymers containing thermally dissociable and soluble groups and the use of such polymers as organic electroluminescent materials MITSUBISHI CHEMICAL CORPORATION (JP) 2014-08-05 — — US disclosed
US-20110192464-A1 POLYMER, LUMINESCENT-LAYER MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT, SOLAR CELL ELEMENT, ORGANIC EL DISPLAY, AND ORGANIC EL LIGHTING EACH OBTAINED USING THESE MITSUBISHI CHEMICAL CORPORATION (JP) 2011-08-11 — — US disclosed
EP-2311894-A1 POLYMER, MATERIAL FOR LUMINESCENT LAYER, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOSITION FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT, SOLAR CELL ELEMENT, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING UTILIZING SAME Mitsubishi Chemical Corporation (JP) 2011-04-20 — — EP disclosed
US-7803953-B2 Catalyst for producing arylamine and process for producing arylamine by means thereof TOSOH CORPORATION (JP) 2010-09-28 — — US disclosed
EP-1864714-A1 Catalyst for producing arylamine and process for producing arylamine by means thereof Tosoh Corporation (JP) 2007-12-12 — — EP disclosed
US-20070282111-A1 Catalyst for producing arylamine and process for producing arylamine by means thereof TOSOH CORPORATION (JP) 2007-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282111-A1 Catalyst for producing arylamine and process for producing arylamine by means thereof TYR, PNMT, INMT CYP1A2 312/4885CYP2C9 326/4885MAPT 3309/4885
US-20110192464-A1 POLYMER, LUMINESCENT-LAYER MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT, SOLAR CELL ELEMENT, ORGANIC EL DISPLAY, AND ORGANIC EL LIGHTING EACH OBTAINED USING THESE LEF1, EPCAM, EBPL CYP1A2 4742/4885CYP2C9 3924/4885MAPT 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback